...
首页> 外文期刊>Open Journal of Psychiatry >The Use of Atypical Neuroleptics in Drugs Management in Fann’s Psychiatry Department
【24h】

The Use of Atypical Neuroleptics in Drugs Management in Fann’s Psychiatry Department

机译:非典型神经抑制因子在Fann精神科部门的药物管理中

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and Objectives: Neuroleptics have revolutionized pharmacological management in psychiatry. The advent of atypical neuroleptics constitutes a major turning point in this therapeutic challenge. The objective of our study was to determine the prescription of these atypical neuroleptics in Fann’s psychiatry department. Methodology: It was a descriptive retrospective cross-sectional study that involved 223 patients hospitalized in the psychiatry department of Fann Hospital during the period from January 2015 to December 2017. Results: Our study shows a majority prescription of classic neuroleptics in combination Haloperidol-Chlorpromazine 53% and 14% in monotherapy and a prescription of atypical neuroleptics at 4%. They are prescribed in combination with the classics at 4%. Conclusion: These results show a still low prescription of atypical neuroleptics which raises questions about the availability and affordability of such drugs, but also about prescription habits in the context of developing country.
机译:背景和目标:神经抑制因素在精神病学中彻底改变了药理学管理。非典型神经抑制因素的出现构成了这种治疗挑战中的重大转折点。我们的研究目的是确定围栏的精神病部门这些非典型神经抑制剂的处方。方法论:2015年1月至2017年1月期间,涉及223名患者在2015年1月至12月期间住院的223名患者。结果:我们的研究表明,联合氟哌啶醇 - 氯氯丙嗪53的经典神经抑制剂的大多数方案显示单药治疗中的%和14%和4%的非典型神经疫苗的处方。它们与经典组合在4%方面开展。结论:这些结果表明,非典型神经抑制剂的仍然低调,这提出了关于这种药物的可用性和可负担性的问题,也是关于发展中国家背景下的处方习惯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号